Securities and exchange commission


Download 479.04 Kb.
NameSecurities and exchange commission
page1/6
A typeExplanatory note
manual-guide.com > manual > Explanatory note
  1   2   3   4   5   6



================================================================================
UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549
----------
FORM 10-Q/A

(Amendment No. 1)
(Mark One)
|X| Quarterly Report Pursuant to Section 13 or 15(d) of the Securities

Exchange Act of 1934
For the Quarter Ended September 30, 2006
OR
|_| Transition Report Pursuant To Section 13 Or 15(d) Of the Securities

Exchange Act of 1934
For the Transition Period from ___________ to _____________
Commission File No. 0-23047
----------
SIGA Technologies, Inc.

(Exact name of registrant as specified in its charter)
A Delaware Corporation IRS Employer No. 13-3864870
420 Lexington Avenue, Suite 408, New York, NY 10170

Telephone Number (212) 672-9100
Indicate by check mark whether the registrant (1) has filed all reports required

to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during

the preceding 12 months (or for such shorter period that the registrant was

required to file such reports), and (2) has been subject to such filing

requirements for the past 90 days. Yes |X| No |_|.
Indicate by check mark whether the registrant is a large accelerated filer, an

accelerated filer, or a non-accelerated filer. See definition of "accelerated

filer and large accelerated filer" in Rule 12b-2 of the Exchange Act. (Check

one):
Large Accelerated Filer |_| Accelerated Filer |_| Non-Accelerated Filer |X|.
Indicate by check mark whether the registrant is a shell company (as defined in

rule 12b-2 of the Exchange Act). Yes |_| No |X|.
As of October 31, 2006 the registrant had 31,765,621 shares of common stock

outstanding.
================================================================================

EXPLANATORY NOTE
This Amendment No. 1 on Form 10-Q/A (this "Amendment") amends the

Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2006

filed on November 1, 2006 (the "Original Filing"). We have filed this Amendment

solely to include the information required by Part II, Item 6 - Exhibits. This

information was inadvertently omitted from the Original Filing. In addition, in

connection with the filing of this Amendment and pursuant to the rules of the

Securities and Exchange Commission, we are including with this Amendment certain

currently dated certifications.
Except as described above, no other changes have been made to the Original

Filing. This Amendment has not resulted in any changes to our previously

reported financial results. This Amendment continues to speak as of the date of

the Original Filing, and we have not updated the disclosures contained in this

Amendment to reflect any events that occurred at a date subsequent to the

Original Filing.
1

Part II

Other information
Item 6. Exhibits
* 10.1 Contract, dated September 29, 2006, between SIGA Technologies, Inc.

and the National Institute of Allergy and Infectious Diseases of the

National Institutes for Health.
* 31 Certification of Chief Financial Officer and Acting Chief Executive

Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
* 32 Certification of Chief Financial Officer and Acting Chief Executive

Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
* Filed herein
2

SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the

registrant has duly caused this report to be signed on its behalf by the

undersigned, thereunto duly authorized.
SIGA Technologies, Inc.

(Registrant)
Date: November 13, 2006 By: /s/ Thomas N. Konatich

------------------------
Thomas N. Konatich
Chief Financial Officer and

Acting Chief Executive Officer
3



EXHIBIT 10.1

ADB No. N01-AI-60014 OMB Approval 2700-0042 / 0990-0115

====================================================================================================================================

|1. THIS CONTRACT IS A RATED ORDER |RATING |PAGE OF PAGES

| UNDER DPAS (15 CFR 350) > | | |

AWARD/CONTRACT | | N/A | 1 | 33

------------------------------------------------------------------------------------------------------------------------------------

2. CONTRACT (Proc. Inst. Ident.) NO. |3. EFFECTIVE DATE |4. REQUISITION/PURCHASE REQUEST/PROJECT NO.

HHSN266200600014C | September 29, 2006 | DMID 2006-0473

------------------------------------------------------------------------------------------------------------------------------------

5. ISSUED BY CODE| |6. ADMINISTERED BY (If other than Item 5) CODE | N/A

----------------------------| -----------------

National Institutes of Health, NIAID |

DEA, Office of Acquisitions | MID RCB-A

6700-B Rockledge Dr., Room 3214, MSC 7612 |

Bethesda, Maryland 20892-7612 |

|

------------------------------------------------------------------------------------------------------------------------------------

7. NAME AND ADDRESS OF CONTRACTOR (No. street, county, state and ZIP Code) |8. DELIVERY

| [ ] FOB ORIGIN [X] OTHER (See below)

SIGA Technologies, Inc. | FOB Destination

4575 SW Research Way, Suite 230 |--------------------------------------------

Corvallis, OR 97333 |9/ DISCOUNT FOR PROMPT PAYMENT

| N/A

|

|--------------------------------------------

|10. SUBMIT INVOICES |ITEM

---------------------------------------------------------------------------------------| |

CODE |FACILITY CODE |ADDRESS SHOWN IN: |Art. G.3

------------------------------------------------------------------------------------------------------------------------------------

11. SHIP TO/MARK FOR CODE | N/A |12. PAYMENT WILL BE MADE BY CODE | N/A

------------------------| -----------------

|

Article F.1 | See Article G.3

|

-----------------------------------------------------------------|------------------------------------------------------------------

13. AUTHORITY FOR USING OTHER FULL AND OPEN COMPETITION: N/A |14. ACCOUNTING AND APPROPRIATION DATA:

| EIN: 1-133864870-AI SOC 25.55 CAN: 6-8467101

[ ] 10 U.S.C. 2304(c)( ) [ ] 41 U.S.C. 253(c)( ) | Obligate: $8,191,538

|

-----------------------------------------------------------------|------------------------------------------------------------------

15A. ITEM NO. | 15B. SUPPLIES/SERVICES | 15C. QUANTITY | 15D. UNIT | 15E. UNIT PRICE | 15F. AMOUNT

-----------------------------------------------------------------|---------------|-----------|--------------------|-----------------

|FY06 | | |$ 3,191,538

Title: NDA Enabling Development for SIGA-246: A
Smallpox |FY07 | | |$10,368,051

Antiviral Drug |FY08 | | |$ 2,984,928

Period: September 29, 2006 - September 28, 2009 | | | |

Contract Type: Cost Reimbursement Completion | | | |

RFP No.: BAA-NIH-NIAID-DMID-06-35 | | | |

------------------------------------------------------------------------------------------------------------------|-----------------

15G. TOTAL AMOUNT OF CONTRACT > |$16,554,517

------------------------------------------------------------------------------------------------------------------------------------

16. TABLE OF CONTENTS

------------------------------------------------------------------------------------------------------------------------------------

(X)| SEC. | DESCRIPTION | PAGE(S) | (X) | SEC. | DESCRIPTION | PAGE(S)

-----------------------------------------------------------------|------------------------------------------------------------------

PART I - THE SCHEDULE | PART II - CONTRACT CLAUSES

-----------------------------------------------------------------|------------------------------------------------------------------

[X]| A |SOLICITATION/CONTRACT FORM | 1 | [X] | I |CONTRACT CLAUSES | 25

----|------|-------------------------------------------|---------|------------------------------------------------------------------

[X]| B |SUPPLIES OR SERVICES AND PRICE/COST | 4 | PART III - LIST OF DOCUMENTS, EXHIBITS AND OTHER ATTACH.

----|------|-------------------------------------------|---------|------------------------------------------------------------------

[X]| C |DESCRIPTION/SPECS./WORK STATEMENT | 7 | [X] | J |LIST OF ATTACHMENTS | 32

----|------|-------------------------------------------|---------|------------------------------------------------------------------

[X]| D |PACKAGING AND MARKING | 12 | PART IV - REPRESENTATIONS AND INSTRUCTIONS

----|------|-------------------------------------------|---------|------------------------------------------------------------------

[X]| E |INSPECTION AND ACCEPTANCE | 12 | [X] | K |REPRESENTATIONS, CERTIFICATIONS | 33

----|------|-------------------------------------------|---------| | |AND OTHER STATEMENTS OF OFFERORS |

[X]| F |DELIVERIES OR PERFORMANCE | 13 | | | |

----|------|-------------------------------------------|---------|-----|------|-------------------------------------------|---------

[X]| G |CONTRACT ADMINISTRATION DATA | 15 | [ ] | L |INSTRS., CONDS., AND NOTICES TO OFFERORS |

----|------|-------------------------------------------|---------|-----|------|-------------------------------------------|---------

[X]| H |SPECIAL CONTRACT REQUIREMENTS | 17 | [ ] | M |EVALUATION FACTORS FOR AWARD |

------------------------------------------------------------------------------------------------------------------------------------

CONTRACTING OFFICER WILL COMPLETE ITEM 17 OR 18 AS APPLICABLE

------------------------------------------------------------------------------------------------------------------------------------

17. [X] CONTRACTOR'S NEGOTIATED AGREEMENT (Contractor is | 18. [ ] AWARD (Contractor is not required to sign this

required to sign this document and return __2__ copies to | document.) Your offer on Solicitation Number

issuing office.) Contractor agrees to furnish and deliver all | __________________________, including the additions or changes

items or perform all the services set forth or otherwise | made by you which additions or changes are set forth in full

identified above and on any continuation sheets for the | above, is hereby accepted as to the items listed above and on

consideration stated herein. The rights and obligations of the | any continuation sheets. This award consummates the contract

parties to this contract shall be subject to and governed by the | which consists of the following documents: (a) the Government's

following documents: (a) this award/contract, (b) the | solicitation and your offer, and (b) this award/contract. No

solicitation, if any, and (c) such provisions, representations, | further contractual document is necessary.

certifications, and specifications, as are attached or |

incorporated by reference herein. (Attachments are listed |

herein.) |

-----------------------------------------------------------------|------------------------------------------------------------------

19A. NAME AND TITLE OF SIGNER (Type or print) |20A. NAME OF CONTRACTING OFFICER

|

Dennis E. Hruby Chief Scientific Officer |Yvette R. Brown, Contracting Officer, MID RCB-A, OA, DEA, NIAID

-----------------------------------------------------------------|------------------------------------------------------------------

19B. NAME OF CONTRACTOR |19C. DATE SIGNED |20B. UNITED STATES OF AMERICA |20C. DATE SIGNED

| | |

/s/ Dennis E. Hruby | |BY /s/ Yvette R. Brown |

--------------------------------------- | | ---------------------------------- |

(Signature of person authorized to sign) | 9/26/06 | (Signature of Contracting Officer) | 9/26/06

====================================================================================================================================

NSN 7540-01-152-8069 26-107 STANDARD FORM 26 (REV. 4-85)

PREVIOUS EDITION UNUSABLE Computer Generated Prescribed by GSA

FAR (48 CFR) 53.214(a)

Contract No. HHSN266200600014C
DETAILED TABLE OF CONTRACT CONTENTS

PART I - THE SCHEDULE
SECTION A - SOLICITATION/CONTRACT FORM
SECTION B - SUPPLIES OR SERVICES AND PRICES/COSTS ..................................................................... 4

ARTICLE B.1. BRIEF DESCRIPTION OF SUPPLIES OR SERVICES ............................................................. 4

ARTICLE B.2. ESTIMATED COST AND FIXED FEE .......................................................................... 4

ARTICLE B.3. PROVISIONS APPLICABLE TO DIRECT COSTS ................................................................. 4

ARTICLE B.4. ADVANCE UNDERSTANDINGS ................................................................................ 5

SECTION C - DESCRIPTION/SPECIFICATIONS/WORK STATEMENT ................................................................. 7

ARTICLE C.1. STATEMENT OF WORK ..................................................................................... 7

ARTICLE C.2. REPORTING REQUIREMENTS ................................................................................ 7

ARTICLE C.3. INVENTION REPORTING REQUIREMENT ....................................................................... 12

SECTION D - PACKAGING, MARKING AND SHIPPING ........................................................................... 12

SECTION E - INSPECTION AND ACCEPTANCE ................................................................................. 12

SECTION F - DELIVERIES OR PERFORMANCE ................................................................................. 13

ARTICLE F.1. DELIVERIES ............................................................................................ 13

ARTICLE F.2. CLAUSES INCORPORATED BY REFERENCE ..................................................................... 15

SECTION G - CONTRACT ADMINISTRATION DATA .............................................................................. 15

ARTICLE G.1. PROJECT OFFICER ....................................................................................... 15

ARTICLE G.2. KEY PERSONNEL ......................................................................................... 16

ARTICLE G.3. INVOICE SUBMISSION/CONTRACT FINANCING REQUEST AND CONTRACT FINANCIAL REPORT ........................... 16

ARTICLE G.4. INDIRECT COST RATES ................................................................................... 16

ARTICLE G.5. POST AWARD EVALUATION OF CONTRACTOR PERFORMANCE ....................................................... 17

SECTION H - SPECIAL CONTRACT REQUIREMENTS ............................................................................. 17

ARTICLE H.1. HUMAN SUBJECTS ........................................................................................ 17

ARTICLE H.2. REQUIRED EDUCATION IN THE PROTECTION OF HUMAN RESEARCH PARTICIPANTS ................................... 18

ARTICLE H.3. DATA AND SAFETY MONITORING IN CLINICAL TRIALS ......................................................... 18

ARTICLE H.4. RESEARCH INVOLVING RECOMBINANT DNA MOLECULES .......................................................... 18

ARTICLE H.5. CONTINUED BAN ON FUNDING OF HUMAN EMBRYO RESEARCH ..................................................... 19

ARTICLE H.6. NEEDLE EXCHANGE ....................................................................................... 19

ARTICLE H.7. PRIVACY ACT ........................................................................................... 19

ARTICLE H.8. ANIMAL WELFARE ........................................................................................ 19

ARTICLE H.9. OMB CLEARANCE ......................................................................................... 20

ARTICLE H.10. SALARY RATE LIMITATION LEGISLATION PROVISIONS ........................................................ 20

ARTICLE H.11. PUBLICATION AND PUBLICITY ............................................................................ 20

ARTICLE H.12. PRESS RELEASES ....................................................................................... 20

ARTICLE H.13. REPORTING MATTERS INVOLVING FRAUD, WASTE AND ABUSE ................................................... 21

ARTICLE H.14. ANTI -LOBBYING ....................................................................................... 21

ARTICLE H.15. OBTAINING AND DISSEMINATING BIOMEDICAL RESEARCH RESOURCES ............................................ 21

ARTICLE H.16. POSSESSION USE AND TRANSFER OF SELECT BIOLOGICAL AGENTS OR TOXINS .................................... 21

ARTICLE H.17. HOTEL AND MOTEL FIRE SAFETY ACT OF 1990 (P.L. 101-391) ............................................... 22

ARTICLE H.18. PROHIBITION ON CONTRACTOR INVOLVEMENT WITH TERRORIST ACTIVITIES ...................................... 23

ARTICLE H.19. NIH POLICY ON ENHANCING PUBLIC ACCESS TO ARCHIVED PUBLICATIONS RESULTING FROM NIH-FUNDED RESEARCH .... 23

ARTICLE H.20. SHARING RESEARCH DATA ................................................................................ 23

ARTICLE H.21. INTELLECTUAL PROPERTY OPTION TO COLLABORATOR ......................................................... 23

ARTICLE H.22. HUMAN MATERIALS ...................................................................................... 24

ARTICLE H.23. HUMAN MATERIALS (ASSURANCE OF OHRP COMPLIANCE) ....................................................... 24
2

Contract No. HHSN266200600014C

  1   2   3   4   5   6

Share in:

Related:

Securities and exchange commission iconNeither the Securities and Exchange Commission nor any state securities...

Securities and exchange commission iconNeither the securities and exchange commission nor any state securities...

Securities and exchange commission iconSecurities and exchange commission

Securities and exchange commission iconSecurities and exchange commission

Securities and exchange commission iconSecurities and exchange commission

Securities and exchange commission iconSecurities and exchange commission

Securities and exchange commission iconSecurities and exchange commission

Securities and exchange commission iconSecurities and exchange commission

Securities and exchange commission iconSecurities and exchange commission

Securities and exchange commission iconSecurities and exchange commission

Securities and exchange commission iconSecurities and exchange commission

Securities and exchange commission iconSecurities and Exchange Commission

Securities and exchange commission iconSecurities and exchange commission

Securities and exchange commission iconSecurities and exchange commission

Securities and exchange commission iconSecurities and exchange commission

Securities and exchange commission iconSecurities and exchange commission

Securities and exchange commission iconSecurities and exchange commission

Securities and exchange commission iconSecurities and exchange commission

Securities and exchange commission iconSecurities and exchange commission

Securities and exchange commission iconSecurities and Exchange Commission




manual


When copying material provide a link © 2017
contacts
manual-guide.com
search